v.sorensen
Submits third-party assay reports on material purchased directly. Based in Curitiba.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
6
n=6
Annotations
0
n=0
Median purity submitted
98.65%
n=5
Suppliers covered
4
n=6
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2025-019427 | Semaglutide | Homopeptide | HOMO-2505-V8950 | Janoshik | 2025-Q3 | 98.64 | 5.35 | 92.5 | Supplier-supplied | 2 | MARGINAL |
| AX-2025-019563 | Semaglutide | Homopeptide | HOMO-2506-M1846 | PeptideMeter | 2025-Q3 | 99.24 | 6.06 | 89.3 | Supplier-supplied | 2 | MARGINAL |
| AX-2025-021015 | 5-Amino-1MQ | WXT | WXT-2505-M3910 | Janoshik | 2025-Q2 | 98.61 | 2.77 | — | Supplier-supplied | 1 | FAIL |
| AX-2025-019942 | Gonadorelin | SWB | SWB-2411-S5667 | Janoshik | 2025-Q2 | 98.65 | 5.46 | 95.2 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-021091 | ARA-290 | WXT | WXT-2502-N5210 | Medutest | 2025-Q2 | 99.37 | 3.74 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019997 | Follistatin-344 | ERP | ERP-2411-Y6431 | VendorInvestigate | 2025-Q1 | N/A | 2.68 | — | Buyer-sourced | 1 | N/A |
| Supplier | Records | Median purity |
|---|---|---|
| Homopeptide | 2 | n<3 |
| WXT | 2 | n<3 |
| SWB | 1 | n<3 |
| ERP | 1 | n<3 |